FDA.reportPublic FDA data

Application 017612

Type
NDA
Sponsor
CADENCE HEALTH

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LO/OVRALETHINYL ESTRADIOL; NORGESTRELTABLET;ORAL-210.03MG;0.3MGNoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
72527SUPPL2022-11-01
72515SUPPL2022-11-01
70907SUPPL2022-05-02
70877SUPPL2022-05-02
49388SUPPL2017-08-15
49315SUPPL2017-08-10
40754SUPPL2003-02-05